The ARIFLO brand, founded in 1996 (United Kingdom), from 1722 sister brands and 17477 competing brands. ARIFLO is a brand of GSK PLC, listed on the stock exchange of Francfort. Its International Securities Identification Number (ISIN) is GB00BN7SWP63. ARIFLO is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
GSK PLC
(ARIFLO)
over 5 years*
EUR 16.30